- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Stryker Corporation (SYK)
Track today's live Stryker (SYK) share price, performance and key data on this page with our current NYSE:SYK stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Stryker share price on the NYSE exchange. Use the dropdown to switch exchange for the SYK share price, head to our technical summary section, which provides analysis on Stryker share price buy/sell indicators using real-time data (or discuss the Stryker (SYK) stock price today with other investors in the Stryker NYSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NYSE:SYK share price (ISIN: US8636671013) to enhance your trading decisions with our free investment tools and resources.
What Is the Stryker Corporation Share Price Today?
The Stryker share price today is 339.03.
What Is the Stock Symbol for Stryker Corporation
The stock symbol (or 'ticker') for Stryker Corporation is "SYK."
What Stock Exchange Does Stryker Corporation Trade On?
Stryker Corporation is listed and trades on the NYSE stock exchange.
Is Stryker Corporation a Good Stock to Buy?
Determining whether Stryker (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NYSE:SYK share price (ISIN: US8636671013) to enhance your trading decisions with our free investment tools and resources.
What Is the Stryker Corporation Share Price Today?
The Stryker share price today is 339.03.
What Is the Stock Symbol for Stryker Corporation
The stock symbol (or 'ticker') for Stryker Corporation is "SYK."
What Stock Exchange Does Stryker Corporation Trade On?
Stryker Corporation is listed and trades on the NYSE stock exchange.
Is Stryker Corporation a Good Stock to Buy?
Determining whether Stryker (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
332.54
340.00
52 wk Range
281.00
396.86
SYK is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
332.54340.00
52 wk Range
281.00396.86
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.04%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.04%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SYK Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
382.04
Upside
+12.69%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 16 consecutive years
Stryker receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Stryker receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
- Stryker receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Stryker receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
23 Buy
5 Hold
0 Sell
Ratings:
28 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 382.04
(+12.69% Upside)
Stryker Corporation SWOT Analysis
Strategic Reshaping | Explore Stryker's portfolio transformation, including the Inari Medical acquisition and Spinal Implants divestiture, aimed at high-growth market segments |
Robotic Surgery Leade | Delve into Stryker's dominance in robotic surgery with the Mako system, driving innovation and market share in orthopedic procedures |
Financial Resilience | Discover Stryker's robust financial performance, with double-digit revenue growth and margin expansion, despite industry challenges |
Analyst Optimism | Learn about analyst perspectives, with price targets ranging from $435 to $450, reflecting confidence in Stryker's growth potential |
Stryker Corporation Earnings Call Summary for Q2/2026
- Stryker Q2 2026 results beat estimates with adjusted EPS of $3.69 vs. $3.49 expected and revenue of $6.6B; shares fell 9.23% after-hours to $315.90.
- Organic sales grew 9.0% with adjusted operating margin expanding 170 bps to 27.4%; recovery continued from earlier cybersecurity incident disruption.
- Full-year guidance narrowed to 8.3%-9.3% organic sales growth and $14.95-$15.10 adjusted EPS, signaling limited upside room despite strong Q2 beat.
- Mako robotic platform achieved record Q2 installations, surpassing 2.5M procedures globally; new Mako RPS partial knee system launched commercially.
- Management expects strong H2 driven by capital equipment demand and elevated backlog, but faces execution risks from supply disruptions and cyber remediation costs.
Last Updated: 30/07/2026, 22:40
Read Full TranscriptEarnings
Latest Release
30/07/2026
EPS / Forecast
3.69 / 3.49
Revenue / Forecast
6.6B / 6.58B
Compare SYK to Peers and Sector
Metrics to compare | SYK | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSYKPeersSector | |
|---|---|---|---|---|
P/E Ratio | 34.9x | 27.6x | −0.4x | |
PEG Ratio | 1.25 | −0.78 | 0.00 | |
Price/Book | 5.4x | 3.9x | 2.6x | |
Price / LTM Sales | 5.0x | 2.7x | 3.0x | |
Upside (Analyst Target) | 12.4% | 0.0% | 48.7% | |
Fair Value Upside | Unlock | 29.0% | 5.6% | Unlock |
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Stryker (NYSE: SYK) Share Price Today?
The Stryker stock price today is 339.03 USD.
What Stock Exchange Does Stryker (SYK) Trade On?
Stryker is listed and trades on the New York Stock Exchange.
What Is the Ticker (Stock Symbol) for Stryker?
The stock symbol (also called a 'ticker') for Stryker is "SYK."
Does Stryker Pay Dividends? What’s The Current SYK Dividend Yield?
Yes, SYK Pays Dividends to its Shareholders. The current Stryker dividend yield is 1.04%.
What Is the Current Stryker Market Capitalisation?
As of today, Stryker (NYSE: SYK) market cap is 129.43B USD.
What Is Stryker's (SYK) Earnings Per Share (TTM)?
The Stryker EPS is currently 9.65 (Trailing Twelve Months).
When Is the Next Stryker Earnings Date?
Stryker's next earnings report will be released on 29/10/2026.
Is SYK a Buy or Sell From a Technical Analyst Perspective?
Based on today's Stryker moving averages and other technical indicators, the daily buy/sell signal for SYK stock is Strong Buy.
How Many Times Has Stryker Stock Split?
Stryker has split 9 times. (See the SYK stock split history page for full effective split date and price information.)
How Many Employees Does Stryker Have?
Stryker has 56000 employees, based on their latest Companies House report.
What is the current trading status of Stryker (NYSE: SYK)?
As of 08/08/2026, Stryker (SYK) is trading at a share price of 339.03 USD, with a previous close of 337.43 USD. The stock has fluctuated within a day range of 332.54 USD to 340.00 USD, while its 52-week range spans from 281.00 USD to 396.86 USD.
What Is Stryker (SYK) Price Target According to Analysts?
The average 12-month price target for Stryker is 382.04 USD, with a high estimate of 465 USD and a low estimate of 315 USD. 23 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +12.69% Upside potential.
What Is the SYK Premarket Price?
SYK's last pre-market stock price is 331.21 USD. The pre-market share volume is 1,710.00, and the stock has decreased by -6.22, or -1.84%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.